$CRWV

Holzer & Holzer investigates Eos Energy after $969.6M loss disclosure. Firm examines whether investors received adequate financial disclosures.

CoreWeave stock dropped 20% despite 110% revenue growth to $1.57B, as massive losses and weak guidance disappointed investors concerned about profitability path.

CoreWeave shares fell 11% despite 110% revenue growth, as widening losses and weak forward guidance raised profitability concerns amid massive debt and negative cash flow.

Shareholder lawsuits filed against CoreWeave, Bath & Body Works, and Vistagen for alleged disclosure violations. Lead plaintiff deadlines set for March 2026.

CoreWeave faces securities class action for allegedly omitting material disclosures about operational risks and supply chain vulnerabilities. Investors with losses over $100K must apply by March 13, 2026.

CoreWeave's stock is volatile but backed by strong fundamentals: $56B revenue backlog, four-fold projected growth through 2027, and massive industry demand for AI infrastructure.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and concealed business risks during 2025, following merger collapse and infrastructure delays.

CoreWeave's stock surged 140% with strong 133% sales growth, but the company faces profitability concerns, $19B debt, and dangerous customer concentration with two clients representing 77% of revenue.

Law firm Hagens Berman investigates CoreWeave for allegedly misleading investors about AI infrastructure capacity and concealing Denton facility delays, triggering $14 billion market cap decline.

Ark Investment increased positions in Figma, CoreWeave, and Recursion Pharmaceuticals Friday, buying growth stocks trading below 2025 peaks based on valuation opportunities and emerging tech trends.

Nvidia poised to beat earnings expectations with strong AI demand, while Intuit struggles with competitive AI threats to its core business, down 42.5% in three months.

CoreWeave faces securities fraud lawsuit for allegedly misrepresenting operational capabilities and failing to disclose supplier concentration risk, causing investor losses during March-December 2025.

CoreWeave faces class action lawsuit alleging false statements about demand fulfillment and concealed risks from single supplier dependence. Investors from March-December 2025 can apply for lead plaintiff status by March 13, 2026.

CoreWeave stock dropped 16% due to data center construction delays and a failed merger. A class action lawsuit was filed over misleading guidance.

Coatue Management exited CoreWeave with 80% gains, reallocating capital toward a new Moderna position ahead of the biotech stock's 50% rally.

CoreWeave investors have until March 13, 2026 to join securities lawsuit alleging material misstatements about operational capacity and supplier risks.

AI infrastructure stocks plummeted as Blue Owl Capital faced financing challenges for a Pennsylvania data center, exposing sector vulnerability to funding disruptions.

CoreWeave shares fell after reports of Blue Owl Capital's data center financing struggles. Both companies denied funding shortfalls, but the market reaction highlights investor concerns about AI infrastructure financing.

AMD guarantees $300M loan for Crusoe Energy via Goldman Sachs, backed by chip buyback agreement to boost AI infrastructure adoption.

CoreWeave's stock surged 120% post-IPO as AI demand boosts GPU rental services. The company faces profitability risks despite strong revenue growth and Nvidia backing.